| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
3e-07 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
6e-07 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-06 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-06 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
2e-06 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-05 |